Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.

Polyzos, Stergios A; Kountouras, Jannis; Anastasilakis, Athanasios D; Makras, Polyzois; Hawa, Gerhard; Sonnleitner, Linda; Missbichler, Albert; Doulberis, Michael; Katsinelos, Panagiotis; Terpos, Evangelos (2018). Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment. Hormones, 17(4), pp. 573-579. Springer 10.1007/s42000-018-0083-8

Text Polyzos-2018-Noggin levels in nonalcoholic fat.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (492kB) | Request a copy

AIM

The evaluation of (a) noggin levels in patients with simple steatosis (SS) vs. nonalcoholic steatohepatitis (NASH) vs. controls, and (b) the effect of combined spironolactone plus vitamin E vs. vitamin E monotherapy on noggin levels in biopsy-proven patients with nonalcoholic fatty liver disease (NAFLD).

METHODS

In the case-control study, 15 patients with SS, 16 with NASH, and 24 controls were included. In the randomized controlled trial, NAFLD patients were assigned to vitamin E (400 IU/d) or spironolactone (25 mg/d) plus vitamin E for 52 weeks.

RESULTS

Noggin levels were lower in SS (5.8 ± 1.5 pmol/l) and NASH (8.7 ± 2.4 pmol/l) patients than in controls (13.7 ± 2.7 pmol/l; p for trend = 0.040), but were similar in SS and NASH patients. After adjustment for potential cofounders, log(noggin) remained different between groups. Log(noggin) levels similarly increased post-treatment in both groups: log(noggin) was not different between groups (p = 0.20), but increased within groups over time (p < 0.001), without a significant group × time interaction (p = 0.62). Log(noggin) significantly increased at month 2 post-treatment (p = 0.008 vs. baseline) and remained stable thereafter.

CONCLUSIONS

Lower noggin levels were observed in NAFLD patients than in controls. Noggin levels increased similarly by either combined low-dose spironolactone plus vitamin E or vitamin E monotherapy.

TRIAL REGISTRATION

NCT01147523.

Interest & Impact

Downloads

1 since deposited on 07 Feb 2019
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item